ADR,SEQ,ROUTE,MULTICONST,NONSERIOUS_SERIOUS_FATAL_NSF
1,1,ORAL USE,Y,N
2,1,ORAL USE,Y,S
3,1,ORAL USE,Y,S
4,1,ORAL USE,Y,F
5,1,ORAL USE,Y,N
